Muscarinic Acetylcholine Receptor M1 Antagonists Pipeline Research Report 2024: Comprehensive Insights on 8+ Drugs Featuring Tonix Pharmaceuticals, BMS, WinSanTor, and Apnimed
21. November 2024 04:27 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Muscarinic Acetylcholine Receptor M1 Antagonists - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This...
STXBP1 Encephalopathy Market Assessment 2024: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access
10. September 2024 11:29 ET
|
Research and Markets
Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "STXBP1 Encephalopathy Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access" report has been...
Botulinum Toxin Market Research 2024 - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts to 2031
06. August 2024 09:12 ET
|
Research and Markets
Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "Botulinum Toxin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
Dementia with Diabetes Pipeline Therapeutics Market Report 2024: Comprehensive Insights About 5+ Companies and 5+ Pipeline Drugs
17. Juli 2024 09:09 ET
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Dementia with Diabetes - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024, Featuring Sanofi, Bristol Myers Squibb, Abbott Laboratories, Takeda Pharmaceutical and Amgen
08. März 2024 04:28 ET
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The chemotherapy...
Epilepsy Epidemiology 10 Year Forecast Report to 2032
25. Januar 2024 07:20 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Epilepsy - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.The report delivers an in-depth understanding of...
Chemotherapy Induced Peripheral Neuropathy Treatment Market to Surge to $2.06 Billion by 2027, New Research Shows
23. Januar 2024 02:38 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The...
Global Market for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders: 2022-23 Data, Forecasts for 2024- 2026 and CAGR Projections through 2028
22. Dezember 2023 05:03 ET
|
Research and Markets
Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders" report has been added to ResearchAndMarkets.com's offering. ...
Sleep Disorders Treatment Global Market Report 2023: Featuring Jazz Pharmaceuticals, Pfizer, Sanofi, Zydus Cadila Group & More
19. April 2023 04:33 ET
|
Research and Markets
Dublin, April 19, 2023 (GLOBE NEWSWIRE) -- The "Sleep Disorders Treatment: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. The report covers the market for...
Global Neuroprotection Markets to 2030: Major World Markets, Promising Areas of Research, Biological Therapies, Unmet Needs
23. November 2021 06:18 ET
|
Research and Markets
Dublin, Nov. 23, 2021 (GLOBE NEWSWIRE) -- The "Neuroprotection - Methods, Drugs, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This...